1994
DOI: 10.1093/carcin/15.2.371
|View full text |Cite
|
Sign up to set email alerts
|

Effect of 4-acetylaminofluorene and other tumour promoters on hepatocellular growth and binucleation

Abstract: The complete liver carcinogen 2-acetylaminofluorene (2-AAF) promoted the outgrowth of large neoplastic liver nodules and hepatocellular carcinomas in diethylnitrosamine-treated rats. 2-AAF did not alter the overall proliferative activity of normal hepatocytes, but suppressed binucleation and induced, on a long-term basis, an increase in proliferative activity and in the fraction of diploid hepatocytes relative to control animals. The analogue 4-acetylaminofluorene (4-AAF) was much less effective than 2-AAF as … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
7
0

Year Published

1998
1998
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(8 citation statements)
references
References 0 publications
1
7
0
Order By: Relevance
“…Several studies indicate that the type of shift is dependent on the cause (Seglen 1997). Although the ploidy was not considered in the present study, the sharp shift toward mononuclear cells was thought to be similar to shifts seen in regenerating rat liver after partial hepatectomy (Auvigne et al 2002;Frederiks et al 1990;Gerlyng et al 1993;Melchiorri et al 1993;Seglen 1997;Wheatley 1972), which is similar to shifts with certain drugs (Gerlyng et al 1994;Seglen 1997).…”
Section: Discussionsupporting
confidence: 59%
See 1 more Smart Citation
“…Several studies indicate that the type of shift is dependent on the cause (Seglen 1997). Although the ploidy was not considered in the present study, the sharp shift toward mononuclear cells was thought to be similar to shifts seen in regenerating rat liver after partial hepatectomy (Auvigne et al 2002;Frederiks et al 1990;Gerlyng et al 1993;Melchiorri et al 1993;Seglen 1997;Wheatley 1972), which is similar to shifts with certain drugs (Gerlyng et al 1994;Seglen 1997).…”
Section: Discussionsupporting
confidence: 59%
“…The binuclear cell population is approximately 30%–40% in normal rat liver (Engelmann et al 1981; Fujii et al 2004; Gerlyng et al 1993; Mossin et al 1994; Seglen 1997; Wheatley 1972). Although the mechanisms are unclear, the ratio of mono- and binuclear hepatocytes is known to change with age (Engelmann et al 1981; Gerlyng et al 1993; Seglen 1997; Wheatley 1972), partial hepatectomy (Auvigne et al 2002; Frederiks et al 1990; Gerlyng et al 1993; Melchiorri et al 1993; Seglen 1997; Wheatley 1972), endocrine status (Lamers 1985; Mossin et al 1994; Wheatley 1972), and certain hepatomitogenic and hepatocarcinogenic drugs (Auvigne et al 2002; Gerlyng et al 1994; Kostka et al 1994; Kostka et al 2000; Melchiorri et al 1993; Palut et al 1992; Seglen 1997).…”
Section: Introductionmentioning
confidence: 99%
“…Because of the more variable results of mitosis of binucleated myocytes than of mononucleated myocytes, it would appear that mitosis in binucleated myocytes is less controlled and perhaps is indicative of a more aberrant process that may terminate further proliferative potential. This has been suggested in the case of hepatocyte binucleation (Gerlyng et al, 1992(Gerlyng et al, , 1994Mossin et al, 1994).…”
Section: Discussionmentioning
confidence: 95%
“…Binucleation and polyploidization are irreversible differentiation events, which have been shown to negatively effect the growth potential of the liver. The diploid hepatocytes show higher proliferative activity than polyploid cells after PH or treatment with mitogenic compounds (43,44). Reduced telomere length is one of the critical factors contributing to cellular aging and replicative senescence (45,46).…”
Section: Discussionmentioning
confidence: 99%